November 21, 2026

Moderna to make milestone payments to NIH for COVID vaccine

Moderna and the US National Institutes of Health had entered into a license agreement related to certain patents concerning the COVID vaccine products

Moderna to make milestone payments to NIH for COVID vaccine
An employee shows the Moderna coronavirus disease (COVID-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, US, Dec 21, 2020.

Reuters

Published : 25 Feb 2023, 03:10 PM

Updated : 25 Feb 2023, 03:09 PM

Moderna Inc will make certain contingent development, commercial and regulatory milestone payments to the US National Institutes of Health (NIH) related to the development of COVID-19 vaccines, the company said in a filing on Friday.

Moderna and the US government agency had entered into a license agreement in December related to certain patents concerning the COVID vaccine products, the filing showed.

The vaccine maker first disclosed the deal in its fourth-quarter earnings release stating it missed profit estimates hurt by the royalty payment to NIH.

Moderna said under the agreement it would pay low single-digit royalties on future net sales and also minimum annual royalties.

Related Stories